Benjamin Edwards Inc. Raises Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Benjamin Edwards Inc. lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 44.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,239 shares of the company’s stock after purchasing an additional 1,003 shares during the period. Benjamin Edwards Inc.’s holdings in Privia Health Group were worth $75,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bank of New York Mellon Corp lifted its holdings in Privia Health Group by 1.6% in the 3rd quarter. Bank of New York Mellon Corp now owns 4,040,027 shares of the company’s stock worth $92,921,000 after purchasing an additional 62,543 shares in the last quarter. New York State Teachers Retirement System increased its holdings in Privia Health Group by 33.8% in the 3rd quarter. New York State Teachers Retirement System now owns 58,204 shares of the company’s stock valued at $1,339,000 after acquiring an additional 14,700 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Privia Health Group by 13.8% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 20,829 shares of the company’s stock worth $479,000 after purchasing an additional 2,518 shares in the last quarter. Strs Ohio boosted its holdings in shares of Privia Health Group by 42.9% during the 3rd quarter. Strs Ohio now owns 20,000 shares of the company’s stock valued at $460,000 after purchasing an additional 6,000 shares during the last quarter. Finally, Emerald Advisers LLC grew its position in shares of Privia Health Group by 6.1% during the third quarter. Emerald Advisers LLC now owns 908,858 shares of the company’s stock valued at $20,904,000 after purchasing an additional 51,944 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Price Performance

Shares of NASDAQ PRVA opened at $18.74 on Friday. Privia Health Group, Inc. has a 1 year low of $17.54 and a 1 year high of $30.15. The firm has a 50-day simple moving average of $19.62 and a two-hundred day simple moving average of $21.12. The company has a market cap of $2.22 billion, a P/E ratio of 98.64, a PEG ratio of 2.56 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The business had revenue of $440.80 million for the quarter, compared to the consensus estimate of $425.81 million. Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. Privia Health Group’s revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.14 earnings per share. As a group, equities research analysts expect that Privia Health Group, Inc. will post 0.26 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Evercore ISI cut their price target on Privia Health Group from $26.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, February 28th. TD Cowen decreased their price target on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating on the stock in a research note on Friday, March 1st. Canaccord Genuity Group dropped their price objective on shares of Privia Health Group from $41.00 to $37.00 and set a “buy” rating for the company in a research note on Tuesday, March 19th. Stifel Nicolaus reduced their target price on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Barclays initiated coverage on shares of Privia Health Group in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $22.00 price target for the company. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $27.62.

Insider Activity

In other Privia Health Group news, CFO David Mountcastle sold 3,933 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $17.77, for a total value of $69,889.41. Following the completion of the sale, the chief financial officer now directly owns 262,279 shares of the company’s stock, valued at approximately $4,660,697.83. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Thomas Bartrum sold 2,252 shares of the stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the transaction, the executive vice president now owns 103,862 shares of the company’s stock, valued at approximately $1,913,138.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO David Mountcastle sold 3,933 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $17.77, for a total value of $69,889.41. Following the transaction, the chief financial officer now owns 262,279 shares in the company, valued at approximately $4,660,697.83. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 31,783 shares of company stock valued at $582,886. 14.20% of the stock is currently owned by company insiders.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.